Biotechnology News and Research

RSS

BIO supports USMCA, appreciates Administration's efforts to prioritize biotechnology innovation

Biotechnology Innovation Organization President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):

5 Oct 2018

Malaria parasites found to be most infectious during mosquito feeding times

Malaria parasites have evolved to be most infectious at the time of day when mosquitoes feed, to maximize the chance of being spread, research shows.

4 Oct 2018

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

4 Oct 2018

Ingenza announces extension of collaboration with Syngenta

Industrial biotech specialist Ingenza has announced that its collaboration with Syngenta for work on efficient technologies to support the development of crop protection products has been extended.

4 Oct 2018

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study showed treatment with baloxavir marboxil significantly reduced the time to improvement of influenza symptoms versus placebo in people at high risk of serious complications from the flu, which includes adults 65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity, or heart disease.

4 Oct 2018

Scientists discover key insights into how sperm and egg cells are formed

Key insights into how sperm and egg cells are formed have been discovered by scientists, shedding light on the earliest stages of their development.

4 Oct 2018

Vegetable hormone helps reverse brain alterations caused by high-fat diets, obesity

The Neurobiotechnology research team of the Universitat Jaume I in Castellón, Spain, headed by professor Ana María Sánchez, has proven the positive effects of a vegetable hormone, helping reverse brain alterations caused by high-fat diets, type-2 diabetes, obesity and physical inactivity.

3 Oct 2018

Researchers obtain understanding of pathomechanisms underlying two age-related eye disorders

Population aging is a global phenomenon with profound medical implications. Tissue dysfunction associated with aging affects all vital organs, including the eyes.

3 Oct 2018

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Genentech, a member of the Roche Group, announced today interim clinical data from the dose-finding parts of the pivotal FIREFISH and SUNFISH studies investigating risdiplam in spinal muscular atrophy.

3 Oct 2018

Novel method promises to reduce production costs for potent form of vitamin K

In an innovative study that promises to reduce production costs for the most potent form of vitamin K -- Menaquinone-7, Penn State researchers have developed a novel method to enhance the fermentation process that creates the supplement by agitated liquid fermentation in a biofilm reactor.

3 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical use, which could leave 1 million people without access to transformative care if such a breakthrough occurs, according to a new RAND Corporation study.

1 Oct 2018

New approach to causality moves away from temporally linear model of cause and effect

Natural little scientists, human babies love letting go of things and watching them fall. Baby's first experiment teaches them about more than the force of gravity.

29 Sep 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, as part of the agency's Small Business Innovation Research Program.

27 Sep 2018

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.

27 Sep 2018

Biotechnology News and Research

BIO supports USMCA, appreciates Administration's efforts to prioritize biotechnology innovation

Malaria parasites found to be most infectious during mosquito feeding times

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Ingenza announces extension of collaboration with Syngenta

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Scientists discover key insights into how sperm and egg cells are formed

Vegetable hormone helps reverse brain alterations caused by high-fat diets, obesity

Researchers obtain understanding of pathomechanisms underlying two age-related eye disorders

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Novel method promises to reduce production costs for potent form of vitamin K

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

New approach to causality moves away from temporally linear model of cause and effect

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

New approach to vaccine development and improved surveillance could help target deadly diseases

Exploring parallels between biological and computing world

Researchers review current state and future potential of biologic medications to treat asthma in children

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News